Actively Recruiting

Age: 19Years +
All Genders
NCT06334471

Whole Genome Sequencing in Breast Cancer

Led by Inocras Korea Inc. · Updated on 2024-04-03

1200

Participants Needed

1

Research Sites

439 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

This study aims to conduct whole genome sequencing in breast cancer patients to elucidate individual genetic characteristics and their correlation with breast cancer subtypes. The primary objective is to establish new treatment guidelines aligned with the paradigm shift in precision medicine. The study will include both prospective and retrospective cohorts totaling 1200 participants. Prospective participants must provide consent and be eligible for tissue collection, while retrospective participants must have histologically confirmed breast cancer and available tissue samples from Samsung Medical Center Biobank. The study period spans 3 years for subject enrollment and 5 years for follow-up observations, with an expected completion date of December 31, 2030.

CONDITIONS

Official Title

Whole Genome Sequencing in Breast Cancer

Who Can Participate

Age: 19Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Patients aged 19 years or older who have provided written consent
  • Patients capable of voluntarily participating in the study
  • Patients eligible for tissue examination and surgical removal to collect samples
  • Patients histologically confirmed with breast cancer or undergoing tissue examination due to imaging findings suggestive of breast cancer
  • Retrospective patients with breast cancer tissue samples collected between 2012 and 2023 stored in the Samsung Medical Center Biobank
Not Eligible

You will not qualify if you...

  • Patients who do not understand or refuse to provide written consent
  • Patients for whom obtaining sufficient tissue samples is difficult
  • Patients who refuse to undergo genetic testing
  • Retrospective patients without adequate stored tissue for analysis

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Samsung Medical Center

Seoul, South Korea

Actively Recruiting

Loading map...

Research Team

J

JeongSeok Lee, MD

CONTACT

H

HyunJung Lee

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here